Laura Restellini
Research Subjects
Laura Restellini has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Isabelle Imbert
Ashland Specialties France, Affiliate of Ashland Inc., 06904 Sophia Antipolis, France
3 shared publications - Capallere Capallere
Ashland Specialties France, Sophia Antipolis, France
2 shared publications - Audrey Le Mestr
Ashland Specialties France, Affiliate of Ashland Inc., 06904 Sophia Antipolis, France
1 shared publication - Catherine Serre
Ashland Specialties France, Affiliate of Ashland Inc., 06904 Sophia Antipolis, France
1 shared publication - Celine Meyrignac
Department of Tissue Engineering and Toxicology In Vitro, Ashland Specialties France, Sophia Antipolis, France
1 shared publication - Hui Ren
R&D Center, Shanghai CHANDO Group Co., Ltd., Shanghai 200233, China
1 shared publication
Latest Publications
- Open Access
Plant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin
In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology™, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection…) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.
Open AccessPlant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin
In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology™, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection…) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.
- 9 September 2022
- Published by Morressier GmbH
ESDR248 - Effect of Myrciaria Dubia On In Vitro Tattoo Model
Insertion of pigments under the skin to create tattoos is around since about 6 000 years old (Neolithic period). Nowadays, United States have mor | POSTER
- 9 September 2022
- Published by Morressier GmbH
ESDR248 - Effect of Myrciaria Dubia On In Vitro Tattoo Model
Insertion of pigments under the skin to create tattoos is around since about 6 000 years old (Neolithic period). Nowadays, United States have mor | POSTER
- Open Access
Addressing Human Skin Ethnicity: Contribution of Tissue Engineering to the Development of Cosmetic Ingredients
Recent publications describe various skin disorders in relation to phototypes and aging. The highest phototypes (III to VI) are more sensitive to acne, with the appearance of dark spots due to the inflammation induced by Cutibacterium acnes (previously Propionibacterium acnes). Dryness with aging is due to a lower activity of specific enzymes involved in the maturation of lipids in the stratum corneum. To observe and understand these cutaneous issues, tissue engineering is a perfect tool. Since several years, pigmented epidermis with melanocytes derived from specific phototypes allow to develop in vitro models for biological investigations. In the present study, several models were developed to study various skin disorders associated with phototypes and aging. These models were also used to evaluate selected ingredients’ ability to decrease the negative effects of acne, inflammation, and cutaneous dryness. Hyperpigmentation was observed on our reconstructed pigmented epidermis after the application of C. acnes, and pollutant (PM10) application induced increased inflammatory cytokine release. Tissue engineering and molecular biology offer the capability to modify genetically cells to decrease the expression of targeted proteins. In our case, GCase was silenced to decrease the maturation of lipids and in turn modify the epidermal barrier function. These in vitro models assisted in the development of ethnic skin-focused cosmetic ingredients.
Open AccessAddressing Human Skin Ethnicity: Contribution of Tissue Engineering to the Development of Cosmetic Ingredients
Recent publications describe various skin disorders in relation to phototypes and aging. The highest phototypes (III to VI) are more sensitive to acne, with the appearance of dark spots due to the inflammation induced by Cutibacterium acnes (previously Propionibacterium acnes). Dryness with aging is due to a lower activity of specific enzymes involved in the maturation of lipids in the stratum corneum. To observe and understand these cutaneous issues, tissue engineering is a perfect tool. Since several years, pigmented epidermis with melanocytes derived from specific phototypes allow to develop in vitro models for biological investigations. In the present study, several models were developed to study various skin disorders associated with phototypes and aging. These models were also used to evaluate selected ingredients’ ability to decrease the negative effects of acne, inflammation, and cutaneous dryness. Hyperpigmentation was observed on our reconstructed pigmented epidermis after the application of C. acnes, and pollutant (PM10) application induced increased inflammatory cytokine release. Tissue engineering and molecular biology offer the capability to modify genetically cells to decrease the expression of targeted proteins. In our case, GCase was silenced to decrease the maturation of lipids and in turn modify the epidermal barrier function. These in vitro models assisted in the development of ethnic skin-focused cosmetic ingredients.